Clinical Trials Logo
  1. Home
  2. Other
  3. NCT05390658
  4. Details
NCT05390658 Clinical Trial

Risk Factors Analysis for Acute Myocardial Infarction Patients

Extracorporeal Membrane Oxygenation Complication Clinical Trial

Official title:
Clinical Features and Risk Factors Analysis for Acute Myocardial Infarction Patients Received ECMO

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05390658
Other study ID # ECOM
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 11, 2020
Est. completion date January 12, 2023

Study information
Verified date May 2022
Source First Affiliated Hospital, Sun Yat-Sen University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

ECMO has been used to save the lives of many critically ill patients with cardiorespiratory dysfunction as important rescue therapy. Though the proportion of ECMO applied to this population has been increasing year by year, clinical outcomes of AMI remain poor with high in-hospital mortality. Thus, it is necessary to characterize clinical features and investigate potentially modifiable factors contributing to outcomes of AMI patients who received ECMO treatment.

Recruitment information / eligibility
Status Recruiting
Enrollment 80
Est. completion date January 12, 2023
Est. primary completion date November 12, 2022
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Clinical diagnosis of Alzheimer's Disease Age more than 18 Exclusion Criteria: Life expectancy <1 year Prolonged cardiac arrest before VA-ECMO therapy (>60 min) Iatrogenic myocardial infarction secondary to a percutaneous coronary intervention VA-ECMO implanted in another center before admission

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Not application
Not application

Locations
Country Name City State
China Genglong Liu Guangzhou State...

Sponsors (1)
Lead Sponsor Collaborator
Genglong Liu

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary Survival rate Survival information from ICU entry to ICU exit 1 month
See also
  Status Clinical Trial Phase
Recruiting NCT05486559 - The ECMO-Free Trial N/A
Recruiting NCT04674657 - Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
Not yet recruiting NCT05306392 - Effects of Induced Moderate Hypothermia on ARDS Patients Under Venovenous ExtraCorporeal Membrane Oxygenation N/A
Terminated NCT02280460 - ECMO: Optimization of Its Use
Completed NCT02271126 - TEG Anticoagulation Monitoring During ECMO Phase 1
Recruiting NCT05444764 - PREdiCtIon of Weanability, Survival and Functional outcomEs After ECLS
Completed NCT03659513 - The Effect of ECMO on the Pharmacokinetics of the Drugs and Their Clinical Efficacy
Not yet recruiting NCT06338345 - Pharmacokinetics and Modelling of Beta-Lactam in ECMO-VA Patients N/A
Completed NCT05948332 - Definition and Management of Right Ventricular Injury in Adult Patients Receiving Extracorporeal Membrane Oxygenation
Recruiting NCT04273607 - Anticoagulation-free VV ECMO for Acute Respiratory Failure Phase 2/Phase 3
Not yet recruiting NCT04956497 - Registry Study of Extracorporeal Cardiopulmonary Resuscitation (eCPR) in China
Completed NCT04052230 - Evolution of Diaphragm Thickness Under Veno-arterial ECMO
Terminated NCT04524585 - Partial Neuromuscular Blockade in Acute Respiratory Distress Syndrome N/A
Completed NCT04620005 - Impact of Extra Corporal Membrane Oxygenation Services on Burnout Development in Intensive Care Units.
Recruiting NCT05721105 - Evaluation of Long-term Quality of Life in Children Supported With ExtraCorporeal Membrane Oxygenation (ECMO)
Recruiting NCT06095518 - DIC Markers and Thrombin Generation Parameters in Patients on ECMO Support: a Pilot Study
Recruiting NCT03965208 - Safety and Efficacy of Bivalirudin Versus Heparin for Systemic Anticoagulation in Extracorporeal Membrane Oxygenation Phase 4
Not yet recruiting NCT05814094 - Red Blood Cell Transfusion in ECMO - A Feasibility Trial N/A
Not yet recruiting NCT06319677 - PK/PD Study of Anti-Infective Drugs in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation Treatment
Completed NCT05338593 - Therapy and Outcome of Prolonged Veno-venous ECMO Therapy of Critically Ill ARDS Patients.